Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


Oncothyreon Inc. 

2601 Fourth Avenue
Suite 500
Seattle  Washington  98121   U.S.A.
Phone: 206-801-2100 Fax: 206-801-2101



 Company News
Oncothyreon Inc. (ONTY) Reports Full Year And Fourth Quarter 2014 Financial Results 3/11/2015 7:37:06 AM
Oncothyreon Inc. (ONTY) Announces Full Year And Fourth Quarter 2014 Financial Results Conference Call 3/3/2015 8:19:00 AM
Oncothyreon Inc. (ONTY) Announces Appointment Of Steven P. James To Board Of Directors 3/3/2015 7:50:44 AM
Oncothyreon Inc. (ONTY) To Present At Upcoming Investor Conferences 2/17/2015 8:24:45 AM
Oncothyreon Inc. (ONTY) Announces Proposed Public Offerings 2/6/2015 7:45:56 AM
Oncothyreon Inc. (ONTY) Prices $22 Million Concurrent Public Offerings Of Common Stock And Preferred Stock 2/6/2015 7:36:14 AM
Adimab LLC. Announces New Partnerships With Acceleron Pharma, Oncothyreon Inc. (ONTY), Surface Oncology And Potenza 1/9/2015 9:48:23 AM
Oncothyreon Inc. (ONTY) Announces Presentation Of Positive ONT-380 Data At San Antonio Breast Cancer Symposium 12/12/2014 7:29:52 AM
Oncothyreon Inc. (ONTY) Strikes $300 Million Cancer Pact With Array BioPharma, Inc. (ARRY) 12/12/2014 7:26:54 AM
Oncothyreon Inc. (ONTY) To Present At Stifel 2014 Healthcare Conference 11/12/2014 10:27:11 AM